Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Prepaid Assets (2016 - 2025)

United Therapeutics' Prepaid Assets history spans 17 years, with the latest figure at $248.9 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 46.67% year-over-year to $248.9 million; the TTM value through Dec 2025 reached $248.9 million, up 46.67%, while the annual FY2025 figure was $248.9 million, 46.67% up from the prior year.
  • Prepaid Assets for Q4 2025 was $248.9 million at United Therapeutics, down from $252.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $252.2 million in Q3 2025 and bottomed at $49.7 million in Q1 2021.
  • The 5-year median for Prepaid Assets is $162.1 million (2022), against an average of $153.3 million.
  • The largest annual shift saw Prepaid Assets surged 118.33% in 2022 before it fell 24.18% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $100.4 million in 2021, then skyrocketed by 118.33% to $219.2 million in 2022, then decreased by 24.18% to $166.2 million in 2023, then rose by 2.11% to $169.7 million in 2024, then soared by 46.67% to $248.9 million in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Prepaid Assets are $248.9 million (Q4 2025), $252.2 million (Q3 2025), and $229.7 million (Q2 2025).